Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129021) titled 'Efficacy and Safety of Fingolimod Adjunctive to Endovascular Treatment for Large Vessel Occlusion Stroke (FATE-ET Study)' on July 29.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Second Affiliated Hospital of the Army Medical University
Condition:
Acute ischemic stroke
Intervention:
Fingolimoid Group:Fingolimod capsule 0.5mg/day for 3 consecutive days
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-07-31
Target Sample Size: Fingolimoid Group:408;Placebo Group:408;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.c...